Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.
Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.
复制标题
DOI:
10.1021/mp100245u
复制
发表时间:
2010-12-06
影响因子:
4.9
通讯作者:
Ferrara KW
中科院分区:
文献类型:
--
作者:
Kheirolomoom A;Mahakian LM;Lai CY;Lindfors HA;Seo JW;Paoli EE;Watson KD;Haynam EM;Ingham ES;Xing L;Cheng RH;Borowsky AD;Cardiff RD;Ferrara KW
Repeated administration of chemotherapeutics is typically required for the effective treatment of highly aggressive tumors and often results in systemic toxicity. We have created a copper-doxorubicin complex within the core of liposomes and applied the resulting particle in multi-dose therapy. Copper and doxorubicin concentrations in the blood pool were similar at 24 hours (~40% of the injected dose) indicating stable circulation of the complex. Highly-quenched doxorubicin fluorescence remained in the blood pool over tens of hours, with fluorescence increasing only with the combination of liposome disruption and copper trans-chelation. At 48 hours after injection, doxorubicin fluorescence within the heart and skin was one-fifth and one-half, respectively, of fluorescence observed with ammonium sulfate-loaded doxorubicin liposomes. After 28 days of twice per week doxorubicin administration of 6 mg/kg, systemic toxicity (cardiac hypertrophy and weight and hair loss) was not detected with the copper-doxorubicin liposomes but was substantial with ammonium sulfate-loaded doxorubicin liposomes. We then incorporated two strategies designed to enhance efficacy, mTOR inhibition (rapamycin) to slow proliferation and therapeutic ultrasound to enhance accumulation and local diffusion. Tumor accumulation was ~10% ID/g and was enhanced approximately two-fold with the addition of therapeutic ultrasound. After the 28-day course of therapy, syngeneic tumors regressed to a pre-malignant phenotype of ~ (1 mm)3 or could not be detected.
登录
查看更多内容
影响因子:
10.8
作者:
Chiu, GNC;Abraham, SA;Bally, MB
通讯作者:
Bally, MB
影响因子:
3.9
作者:
GREENAWAY, FT;DABROWIAK, JC
通讯作者:
DABROWIAK, JC
影响因子:
3.4
作者:
MADDEN, TD;HARRIGAN, PR;CULLIS, PR
通讯作者:
CULLIS, PR
影响因子:
5.8
作者:
Dicko, Awa;Tardi, Paul;Mayer, Lawrence
通讯作者:
Mayer, Lawrence
影响因子:
3.7
作者:
Ramsay, Euan;Alnajim, Jehan;Bally, Marcel
通讯作者:
Bally, Marcel